Real-World Outcomes in Eyes With Neovascular AMD Switched From Brolucizumab to Faricimab: A TRUCKEE Study Analysis. Soylu C, Corradetti G, Alhelaly M, Khan H, et al. Am J Ophthalmol 2025;280:169-175.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Soylu C, Corradetti G, Alhelaly M, Khan H, et al. Real-World Outcomes in Eyes With Neovascular AMD Switched From Brolucizumab to Faricimab: A TRUCKEE Study Analysis. Am J Ophthalmol 2025;280:169-175.
PMID: 40816663